Menu

1 / 2

Ligand Pharmaceuticals Incorporated (LGND) M&A Call Transcript

Seeking Alpha·SA Transcripts·7 months ago
#0m2BYyvV
#source#chevron#alpha#ligand#melanie
Reading 0:00
15s threshold

Ligand Pharmaceuticals Incorporated ( LGND ) M&A Call April 27, 2026 8:00 AM EDT

Company Participants

Melanie Herman

Todd Davis - CEO & Director

Octavio Espinoza - Chief Financial Officer

Lauren Hay

Conference Call Participants

Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division

Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division

Yigal Nochomovitz - Citigroup Inc., Research Division

Joseph Pantginis - H.C. Wainwright & Co, LLC, Research Division

Jason Zemansky

Lawrence Solow - CJS Securities, Inc.

Presentation

Operator

Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to Ligand Pharmaceuticals to acquire XOMA Royalty. [Operator Instructions]

I would now like to turn the conference over to Melanie Herman, Head of Investor Relations.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.